Tumor Tests (CLIA) Kits

Chemiluminescent immunoassay test kits for high-sensitivity detection of analytes in clinical diagnostics. These kits are designed for use in automated laboratory analyzer systems.

Chemiluminescence immunoassay kits meeting Clinical Laboratory Improvement Amendments standards for in vitro diagnostics. These kits provide reliable quantitative and qualitative results for clinical laboratory use.

In vitro diagnostic kits for detection and quantification of cancer biomarkers in patient samples. Available in multiple formats including ELISA and CLIA for oncology applications.

Immunoassay kits for measurement of various tumor markers in serum samples. Supports cancer screening, diagnosis, and surveillance.

Immunoassay test kits for detection of various tumor-associated biomarkers in serum and plasma samples. Utilized for cancer screening, diagnosis, and monitoring in oncology.

A series of chemiluminescence-based immunoassay kits for detection of various analytes. Provide high sensitivity and accuracy for clinical laboratory immunoassay applications.

Immunoassay systems for detecting cancer biomarkers in serum and plasma. Supports oncology screening and treatment monitoring applications.

Diagnostic kits for detection and quantification of tumor-associated markers for oncology applications. Supports cancer screening, diagnosis, and treatment monitoring in clinical practice.

In vitro diagnostic test kits based on microarray chemiluminescence immunoassay technology. These kits employ hard substrate glass slides with covalently bound monoclonal antibodies, enabling parallel testing of multiple biomarkers with enhanced sensitivity and accuracy.

ELISA test kits for in vitro diagnostics of human diseases, including determination of tumor markers, hormones, infection markers, and humoral immunity parameters. These tests are designed for clinical diagnostic applications in human medicine.

Diagnostic test kits for detection of infectious disease markers and pathogens. Part of the company's product portfolio utilizing immunochromatographic and chemiluminescence platforms.

Chemiluminescence kits for pathogen detection and identification using lyophilized reagents. Designed for automated quantitative molecular diagnostics including RT-qPCR assays with internal controls to ensure reliable results across sample collection, nucleic acid extraction, and amplification workflows.